TGS Baltic has advised InMedica and its shareholders INVL Baltic Sea Growth Fund and Litgaja on the merger with the MediCA Group. Cobalt advised MediCA.
"Post-transaction, one of the largest Baltic private equity funds INVL Baltic Sea Growth Fund (through its special purpose vehicle ‘BSGF Sanus’) remains the largest shareholder, with an ownership stake of 45% of InMedica shares, 40% is owned by the largest Latvian private medicine group Repharm, and the remaining 15% is held by Lithuanian company Litgaja," Cobalt informed.
Invalda INVL group company INVL Baltic Sea Growth Fund is a Baltic private equity fund. The group’s companies manage pension and mutual funds, alternative investments, individual portfolios, private equity assets, and other financial instruments.
InMedica and the MediCA Group are private medical chains operating in Lithuania.
The TGS Baltic team included Executive Partner Marius Matonis, Partners Aurimas Pauliukevicius and Dalia Tamasauskaite-Ziliene, Senior Associate Julija Eymirlioglu, and Associates Paulius Dabulskis, Rimante Varapnicke, Auguste Linauskaite, and Edvinas Einoris.
The Cobalt team included Partners Elijus Burgis and Rasa Zasciurinskaite and Senior Associates Julija Aleska and Laura Ryzgelyte.
